Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells-Reference-Cited by-同舟云学术

Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells

Published:2018-07-04 Issue:7 Volume:19 Page:1958
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Capozzi Antonella,Mattei Vincenzo,Martellucci Stefano,Manganelli Valeria,Saccomanni Giuseppe,Garofalo Tina^ORCID,Sorice Maurizio,Manera Clementina,Misasi Roberta

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/7/1958/pdf

Reference51 articles.

1. Molecular characterization of a peripheral receptor for cannabinoids

2. Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

3. A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

4. Cannabinoids for Cancer Treatment: Progress and Promise: Figure 1.

5. Towards the use of cannabinoids as antitumour agents

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoids and triple-negative breast cancer treatment;Frontiers in Immunology;2024-08-08

2. Cannabis use associated with lower mortality among hospitalized Covid-19 patients using the national inpatient sample: an epidemiological study;Journal of Cannabis Research;2024-04-06

3. Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic;European Journal of Medicinal Chemistry;2023-11

4. Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential;Current Medicinal Chemistry;2023-04

5. New cannabinoid receptor type 1 and 2 agonists and applications to understanding the endocannabinoid system: A chemical approach;Neurobiology and Physiology of the Endocannabinoid System;2023